Ngā hua rapu - Richard Hernandez
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
475 GEN-011–101 (the TiTAN-1 trial): phase 1 study to evaluate the safety, proliferation and persistence of GEN-011, an autologous neoantigen-targeted peripheral T cell therapy in... mā Thomas Davis, Jessica Price, Arthur DeCillis, Richard Hernandez, Kevin Mancini, Craig Carey
I whakaputaina 2021-11-01Tuhinga -
2
390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid... mā Thomas Davis, Jessica Price, Ammar Sukari, Roger Cohen, Przemyslaw Twardowski, Jessica Flechtner, Melissa Johnson, Maura Gillison, Rudy Lackner, Arthur DeCillis, Richard Hernandez, Kevin Mancini, Mara Shainheit
I whakaputaina 2020-11-01Tuhinga -
3
485 Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors mā Thomas Davis, Jessica Price, Mark Awad, Ammar Sukari, Roger Cohen, Mark Stein, Przemyslaw Twardowski, Jessica Flechtner, Melissa Johnson, Maura Gillison, Rudy Lackner, Arthur DeCillis, Richard Hernandez, Kevin Mancini, Mara Shainheit, Gabriella Santone, Syukri Shukor, Ece Bicak, Vijetha Vemulapalli, Emily Tjon
I whakaputaina 2021-11-01Tuhinga